Ferric carboxymaltose

Generic Name
Ferric carboxymaltose
Brand Names
Injectafer
Drug Type
Small Molecule
Chemical Formula
-
CAS Number
9007-72-1
Unique Ingredient Identifier
6897GXD6OE
Background

Ferric Carboxymaltose is an iron replacement product and chemically, an iron carbohydrate complex. FDA approved on July 25, 2013.

Indication

Ferric carboxymaltose is an iron replacement product indicated for the treatment of iron deficiency anemia in patients ≥1 year of age who have an intolerance to, or unsatisfactory response from, oral iron therapy. It is also indicated in adult patients who have non-dialysis-dependent chronic kidney disease.

Associated Conditions
Iron Deficiency Anemia (IDA)
Associated Therapies
-

Intravenous Iron and High Altitude

Phase 4
Recruiting
Conditions
Interventions
First Posted Date
2024-11-13
Last Posted Date
2024-11-13
Lead Sponsor
United States Army Research Institute of Environmental Medicine
Target Recruit Count
24
Registration Number
NCT06686693
Locations
🇺🇸

USARIEM, Natick, Massachusetts, United States

Hypoferritinemia Without Anemia Among Reproductive Age Females

First Posted Date
2024-05-31
Last Posted Date
2024-06-04
Lead Sponsor
Akram Medical Complex
Target Recruit Count
1331
Registration Number
NCT06437080
Locations
🇵🇰

Fatima Memorial Hospital, Lahore, Punjab, Pakistan

🇵🇰

General Hospital Lahore, Lahore, Punjab, Pakistan

🇵🇰

Sir Gangaram Hospital, Lahore, Punjab, Pakistan

and more 1 locations

IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency

First Posted Date
2024-05-30
Last Posted Date
2024-06-03
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Target Recruit Count
99
Registration Number
NCT06434025
Locations
🇧🇷

Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil

IV Iron-induced Hypophosphatemia After RYGB

First Posted Date
2024-04-08
Last Posted Date
2024-08-20
Lead Sponsor
Lucie Favre
Target Recruit Count
94
Registration Number
NCT06350955
Locations
🇨🇭

CHUV, Lausanne, Vaud, Switzerland

The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures

First Posted Date
2023-10-12
Last Posted Date
2023-10-24
Lead Sponsor
Istanbul University
Target Recruit Count
200
Registration Number
NCT06080893
Locations
🇹🇷

Istanbul University, Istanbul Faculty of Medicine, Department Orthopaedics and Traumatology, Istanbul, Çapa / Fatih, Turkey

Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial

First Posted Date
2023-02-24
Last Posted Date
2024-10-21
Lead Sponsor
Jon Unosson
Target Recruit Count
338
Registration Number
NCT05744219
Locations
🇸🇪

Uppsala University Hospital, Uppsala, Sverige, Sweden

Neuroimaging Ancillary Study

First Posted Date
2022-09-19
Last Posted Date
2024-05-24
Lead Sponsor
Thomas Jefferson University
Target Recruit Count
184
Registration Number
NCT05545527
Locations
🇮🇳

Jawaharlal Nehru Medical College, Belgaum, Karnataka, India

RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study

First Posted Date
2022-08-17
Last Posted Date
2023-11-29
Lead Sponsor
Thomas Jefferson University
Target Recruit Count
538
Registration Number
NCT05504863
Locations
🇮🇳

Jawaharlal Nehru Medical College, Belgaum, Karnataka, India

🇮🇳

S. Nijalingappa Medical College, Bagalkot, Karnataka, India

🇮🇳

Raichur Institute of Medical Sciences, Raichur, Karnataka, India

Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial

First Posted Date
2022-05-03
Last Posted Date
2024-05-24
Lead Sponsor
Thomas Jefferson University
Target Recruit Count
4368
Registration Number
NCT05358509
Locations
🇮🇳

Sawai Man Singh Medical College, Jaipur, Rajasthan, India

🇮🇳

Jawaharlal Nehru Medical College, Belgaum, Karnataka, India

🇮🇳

Raichur Institute of Medical Sciences, Raichur, Karnataka, India

and more 1 locations
© Copyright 2024. All Rights Reserved by MedPath